Daniel Bright

Since joining Carpmaels & Ransford in 2019, Daniel has built up a wealth of patent experience through his work in the Pharmaceuticals and Chemistry teams. He handles a wide variety of subject matter and has experience working on cases relating to new chemical entities, medical uses, pharmaceutical formulations, crystalline forms and consumer products. He has also been involved with work in all aspects of the life span of a patent, from the drafting of new applications to working on contentious matters post-grant. Daniel co-ordinates prosecution of numerous portfolios of European patent applications and pan-European SPC filings relating to marketed drugs and has built up experience in attacking and defending patents in EPO oppositions through these projects.

Prior to joining the firm, Daniel worked for a technology transfer company for Imperial College London. His role involved identifying patentable and commercially valuable inventions produced at the university and managing the company’s Physical Science patent portfolios. This work gave him a unique insight into the variety of commercial considerations that inform patent filing strategies.

In July 2018, Daniel completed a master’s degree at New College, Oxford. His fourth year research project focussed on configurational disorder in metal-organic framework compounds. He used single crystal x-ray diffraction in combination with computational methods to identify the structure of and examine the behaviour of materials with unconventional crystal structures. Daniel was awarded a first-class degree and received special recognition for his master’s year project, being named as the runner-up for the 2018 thesis prize by the Oxford University Honour School of Chemistry.

Outside of the office, Daniel can usually be found marathon training or playing squash with friends. He also enjoys improving his German language skills.